Akzo Nobel (AKZOY)
OTHER OTC:AKZOY
Top Page
Akzo Nobel
(OTC:AKZOY)
Select Model
Select Model
Rating:66Neutral
Price Target:
$22.00
â–¼(-3.76% Downside)
Action:ReiteratedDate:02/06/26
AKZOY scores in the mid-60s driven primarily by improving profitability and cash generation, tempered by declining 2025 revenue and still-elevated leverage. Technicals are moderately positive (price above key moving averages with positive MACD), while valuation is reasonable with a supportive dividend. The latest earnings call adds modest upside due to cost-driven 2026 EBITDA growth guidance, balanced by near-term volume/FX headwinds and reduced buyback support.
Positive Factors
Improved Profitability
Margins have meaningfully recovered from the 2022 trough, with net margin roughly doubling by 2025. This reflects better pricing, cost control and operational leverage that support sustainable earnings power and resilience across cycles even if top-line growth slows.
Negative Factors
Elevated Leverage
Leverage is meaningfully higher than pre-2022 levels, leaving the company with less cushion against demand shocks. With operating cash flow modest relative to debt, capital structure constraints could limit investment optionality and slow down rapid deleveraging in adverse scenarios.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved Profitability
Margins have meaningfully recovered from the 2022 trough, with net margin roughly doubling by 2025. This reflects better pricing, cost control and operational leverage that support sustainable earnings power and resilience across cycles even if top-line growth slows.
Read all positive factors
Akzo Nobel (AKZOY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$10.35B
Dividend Yield3.1%
Average Volume (3M)11.20K
Price to Earnings (P/E)4.3
Beta (1Y)0.52
Revenue Growth-0.12%
EPS Growth-91.96%
CountryUS
Employees34,100
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)0.22
Shares Outstanding513,130,100
10 Day Avg. Volume0
30 Day Avg. Volume11,201
Financial Highlights & Ratios
PEG Ratio1.31
Price to Book (P/B)2.17
Price to Sales (P/S)1.04
P/FCF Ratio17.36
Enterprise Value/Market Cap1.17
Enterprise Value/Revenue1.19
Enterprise Value/Gross Profit2.98
Enterprise Value/Ebitda7.81
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.57
Revenue Forecast (FY)$11.56B
Akzo Nobel Business Overview & Revenue Model
Company Description
Akzo Nobel N.V. engages in the production and sale of paints and coatings worldwide. It offers decorative paints, including paints, lacquers, and varnishes; and a range of mixing machines and color concepts for the building and renovation industry...
How the Company Makes Money
Akzo Nobel primarily makes money by selling paints and coatings products to a wide range of customers, generating revenue from the volume of coatings sold and the pricing it can achieve based on product performance, brand strength, and service. A ...
Akzo Nobel Earnings Call Summary
Earnings Call Date:Feb 03, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Apr 22, 2026
Earnings Call Sentiment Positive
The call showed solid operational execution — delivering EBITDA and margin improvements, strong free cash flow, significant cost savings and a high-value India divestment — which offset market softness and FX headwinds. Management provided a conservative 2026 outlook with a clear, cost-driven plan to lift adjusted EBITDA by at least EUR 100 million and a strategically significant proposed merger with Axalta that targets meaningful synergies. Key near-term risks are lower volumes, FX translation impacts, and a temporary packaging market setback, but the company’s cash generation, deleveraging and efficiency progress drive a constructive outlook.Positive Updates
Full-Year Adjusted EBITDA and Margin Improvement
Full-year adjusted EBITDA of EUR 1,444 million (adjusted for FX translation and India divestment), within ~1% of constant-currency guidance; full-year profitability (adjusted EBITDA margin) 14.2%, up 40 basis points versus prior year.
Negative Updates
Volume Declines and Soft End Markets
Q4 volumes down 2% year-on-year; group organic sales declined 1% (volumes -2%, price/mix +1%); company expects a weak first half of 2026 with no material market recovery in 2026.
Read all updates
Q4-2025 Updates
Positive
Negative
Full-Year Adjusted EBITDA and Margin Improvement
Full-year adjusted EBITDA of EUR 1,444 million (adjusted for FX translation and India divestment), within ~1% of constant-currency guidance; full-year profitability (adjusted EBITDA margin) 14.2%, up 40 basis points versus prior year.
Read all positive updates
Company Guidance
For 2026 Akzo Nobel guided to at least a EUR 100m increase in full‑year adjusted EBITDA on a comparable basis (reported adjusted EBITDA at or above EUR 1.47bn after a EUR 40m scope adjustment for the India divestment and an expected ~EUR 35m FX translation headwind), with volumes expected to be broadly flat (Q1 similar to Q4, a ~EUR 30m FX drag in Q1) and an improving market trajectory in H2; the step‑up is driven by cost actions — the Industrial Excellence Program is expected to deliver ~EUR 90m net savings in 2026 (EUR 110m carryover in 2027; EUR 300m total gross), the SG&A program will deliver EUR 200m gross savings in total (EUR 145m realized to date, ≥EUR 50m carryover in 2026 via ~2,900 role eliminations), together ~EUR 0.5bn of cost takeout — management also expects pricing to be positive in 2026 (after +1% price/mix in 2025) and to finish the year with working capital around or just below ~14.5% (midterm target 13–14%).Akzo Nobel Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
58
Neutral
Cash Flow
63
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 9.76B | 10.71B | 10.67B | 10.85B | 9.59B |
| Gross Profit | 3.89B | 4.34B | 4.23B | 3.92B | 3.85B |
| EBITDA | 1.48B | 1.40B | 1.33B | 1.05B | 1.53B |
| Net Income | 609.94M | 542.00M | 442.00M | 352.00M | 829.00M |
Balance Sheet | |||||
| Total Assets | 13.95B | 14.25B | 14.56B | 14.74B | 13.88B |
| Cash, Cash Equivalents and Short-Term Investments | 1.92B | 1.47B | 1.78B | 1.79B | 1.21B |
| Total Debt | 4.86B | 5.37B | 5.56B | 5.88B | 3.55B |
| Total Liabilities | 9.13B | 9.43B | 10.01B | 10.19B | 8.24B |
| Stockholders Equity | 4.66B | 4.57B | 4.32B | 4.33B | 5.42B |
Cash Flow | |||||
| Free Cash Flow | 582.08M | 362.00M | 834.00M | -38.00M | 317.00M |
| Operating Cash Flow | 878.89M | 668.00M | 1.12B | 254.00M | 605.00M |
| Investing Cash Flow | 407.27M | -132.00M | -144.00M | -1.09B | -134.00M |
| Financing Cash Flow | -925.95M | -684.00M | -827.00M | 1.14B | -974.00M |
Akzo Nobel Technical Analysis
Neutral
22.86
Price Trends
21.45
Negative
21.89
Negative
22.37
Negative
Market Momentum
-0.59
Negative
52.62
Neutral
34.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AKZOY, the sentiment is Neutral. The current price of 22.86 is above the 20-day moving average (MA) of 19.23, above the 50-day MA of 21.45, and above the 200-day MA of 22.37, indicating a neutral trend. The MACD of -0.59 indicates Negative momentum. The RSI at 52.62 is Neutral, neither overbought nor oversold. The STOCH value of 34.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AKZOY.
Akzo Nobel Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $13.92B | 21.09 | 21.80% | 1.96% | 3.09% | 12.25% | |
70 Outperform | $8.99B | 31.70 | 7.29% | 1.25% | 3.87% | -10.30% | |
68 Neutral | $24.69B | 14.71 | 33.60% | 2.71% | -12.98% | -11.34% | |
67 Neutral | $83.17B | 31.08 | 58.53% | 0.98% | 0.96% | 1.96% | |
66 Neutral | $10.35B | 4.27 | 14.61% | 3.10% | -0.12% | -91.96% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | $19.57B | -21.54 | -3.77% | 1.74% | 2.42% | -196.54% |
* Basic Materials Sector Average
AKZOY
Akzo Nobel
20.22
1.72
9.28%
PPG
PPG Industries
110.47
14.47
15.08%
RPM
RPM International
108.72
8.22
8.18%
SHW
Sherwin-Williams Company
335.67
8.68
2.66%
ESI
Element Solutions
36.90
19.11
107.42%
DD
DuPont de Nemours
47.85
24.22
102.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.